$GILD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GILEAD SCIENCES INC. Get notifications about new insider transactions in GILEAD SCIENCES INC for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 46 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 23.60 | 50,000 | 1,180,000 | 500,000 | |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 83.69 | 30,723 | 2,571,125 | 2,996,766 | 3 M to 3 M (-1.01 %) |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 83.35 | 19,277 | 1,606,699 | 3,027,489 | 3 M to 3 M (-0.63 %) |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 23.60 | 50,000 | 1,180,000 | 3,046,766 | 3 M to 3 M (+1.67 %) |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Option Exercise | A | 83.49 | 62,910 | 5,252,356 | 62,910 | |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Option Exercise | M | 40.56 | 17,250 | 699,660 | 72,846 | |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Sell | S | 83.66 | 15,214 | 1,272,805 | 37,738 | 53 K to 37.7 K (-28.73 %) |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Sell | S | 83.29 | 9,786 | 815,055 | 52,952 | 62.7 K to 53 K (-15.60 %) |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Buy | M | 40.56 | 17,250 | 699,660 | 62,738 | 45.5 K to 62.7 K (+37.92 %) |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | A | 83.49 | 94,360 | 7,878,116 | 94,360 | |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | A | 83.49 | 100,650 | 8,403,269 | 100,650 | |
| Feb 02 2018 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Option Exercise | M | 0.00 | 620 | 0 | 4,092 | |
| Feb 02 2018 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Payment of Exercise | F | 83.49 | 218 | 18,201 | 15,329 | 15.5 K to 15.3 K (-1.40 %) |
| Feb 02 2018 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Buy | M | 0.00 | 620 | 0 | 15,547 | 14.9 K to 15.5 K (+4.15 %) |
| Feb 02 2018 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Payment of Exercise | F | 83.80 | 2,259 | 189,304 | 14,927 | 17.2 K to 14.9 K (-13.14 %) |
| Feb 02 2018 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Grant | A | 0.00 | 7,110 | 0 | 17,186 | 10.1 K to 17.2 K (+70.56 %) |
| Feb 02 2018 | GILD | GILEAD SCIENCES IN ... | BARTON JACQUELINE K | Director | Option Exercise | A | 0.00 | 480 | 0 | 480 | |
| Feb 02 2018 | GILD | GILEAD SCIENCES IN ... | BARTON JACQUELINE K | Director | Option Exercise | A | 83.80 | 2,119 | 177,572 | 2,119 | |
| Jan 18 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Option Exercise | M | 21.58 | 100,000 | 2,157,500 | 0 | |
| Jan 18 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Sell | S | 80.99 | 24,843 | 2,012,097 | 2,715 | 27.6 K to 2.7 K (-90.15 %) |
| Jan 18 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Sell | S | 80.00 | 75,157 | 6,012,267 | 27,558 | 102.7 K to 27.6 K (-73.17 %) |
| Jan 18 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Buy | M | 21.58 | 100,000 | 2,157,500 | 102,715 | 2.7 K to 102.7 K (+3,683.24 %) |
| Jan 16 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Option Exercise | M | 40.56 | 18,374 | 745,249 | 90,096 | |
| Jan 16 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Option Exercise | M | 24.91 | 7,501 | 186,812 | 0 | |
| Jan 16 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Sell | S | 79.00 | 4,125 | 325,875 | 45,488 | 49.6 K to 45.5 K (-8.31 %) |
| Jan 16 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Sell | S | 79.00 | 18,374 | 1,451,546 | 49,613 | 68 K to 49.6 K (-27.03 %) |
| Jan 16 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Sell | S | 79.00 | 7,501 | 592,579 | 67,987 | 75.5 K to 68 K (-9.94 %) |
| Jan 16 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Buy | M | 40.56 | 18,374 | 745,249 | 75,488 | 57.1 K to 75.5 K (+32.17 %) |
| Jan 16 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Buy | M | 24.91 | 7,501 | 186,812 | 57,114 | 49.6 K to 57.1 K (+15.12 %) |
| Jan 04 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Option Exercise | M | 24.91 | 8,625 | 214,806 | 7,501 | |
| Jan 04 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Sell | S | 73.86 | 5,675 | 419,133 | 49,613 | 55.3 K to 49.6 K (-10.26 %) |
| Jan 04 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Sell | S | 72.34 | 700 | 50,636 | 55,288 | 56 K to 55.3 K (-1.25 %) |
| Jan 04 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Sell | S | 74.00 | 8,625 | 638,250 | 55,988 | 64.6 K to 56 K (-13.35 %) |
| Jan 04 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Buy | M | 24.91 | 8,625 | 214,806 | 64,613 | 56 K to 64.6 K (+15.41 %) |
| Jan 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 23.60 | 50,000 | 1,180,000 | 550,000 | |
| Jan 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 73.95 | 18,954 | 1,401,614 | 2,996,766 | 3 M to 3 M (-0.63 %) |
| Jan 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 73.60 | 26,941 | 1,982,987 | 3,015,720 | 3 M to 3 M (-0.89 %) |
| Jan 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 72.26 | 4,105 | 296,634 | 3,042,661 | 3 M to 3 M (-0.13 %) |
| Jan 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 23.60 | 50,000 | 1,180,000 | 3,046,766 | 3 M to 3 M (+1.67 %) |
| Jan 02 2018 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 46 | 0 | 6,493 | |
| Jan 02 2018 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | A | 0.00 | 195 | 0 | 27,349 | |
| Jan 02 2018 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 151 | 0 | 21,199 | |
| Dec 05 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 21.58 | 73,333 | 1,582,159 | 0 | |
| Dec 05 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 74.35 | 12,500 | 929,409 | 2,996,766 | 3 M to 3 M (-0.42 %) |
| Dec 05 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 75.57 | 101 | 7,633 | 3,009,266 | 3 M to 3 M (0.00 %) |
| Dec 05 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 75.11 | 60,732 | 4,561,344 | 3,009,367 | 3.1 M to 3 M (-1.98 %) |
| Dec 05 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 21.58 | 73,333 | 1,582,159 | 3,070,099 | 3 M to 3.1 M (+2.45 %) |
| Dec 05 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Option Exercise | M | 24.91 | 8,625 | 214,806 | 16,126 | |
| Dec 05 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Sell | S | 75.20 | 3,600 | 270,716 | 55,988 | 59.6 K to 56 K (-6.04 %) |
| Dec 05 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Sell | S | 74.46 | 11,400 | 848,836 | 59,588 | 71 K to 59.6 K (-16.06 %) |
| Dec 05 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Buy | M | 24.91 | 8,625 | 214,806 | 70,988 | 62.4 K to 71 K (+13.83 %) |
| Nov 21 2017 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 10,000 | 0 | 2,308,407 | 2.3 M to 2.3 M (-0.43 %) |
| Nov 15 2017 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | M | 21.58 | 220,000 | 4,746,500 | 0 | |
| Nov 15 2017 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 72.88 | 220,000 | 16,034,678 | 1,165,924 | 1.4 M to 1.2 M (-15.87 %) |
| Nov 15 2017 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Buy | M | 21.58 | 220,000 | 4,746,500 | 1,385,924 | 1.2 M to 1.4 M (+18.87 %) |
| Nov 13 2017 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Payment of Exercise | F | 73.02 | 3,422 | 249,874 | 10,076 | 13.5 K to 10.1 K (-25.35 %) |
| Nov 13 2017 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Grant | A | 0.00 | 6,810 | 0 | 13,498 | 6.7 K to 13.5 K (+101.82 %) |
| Nov 13 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Gift | G | 0.00 | 1,327 | 0 | 129,760 | 128.4 K to 129.8 K (+1.03 %) |
| Nov 13 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Gift | G | 0.00 | 1,327 | 0 | 2,715 | 4 K to 2.7 K (-32.83 %) |
| Nov 13 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Payment of Exercise | F | 73.02 | 1,373 | 100,256 | 4,042 | 5.4 K to 4 K (-25.36 %) |
| Nov 13 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Grant | A | 0.00 | 2,700 | 0 | 5,415 | 2.7 K to 5.4 K (+99.45 %) |
| Nov 07 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Option Exercise | M | 0.00 | 4,500 | 0 | 4,460 | |
| Nov 07 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Gift | G | 0.00 | 2,288 | 0 | 128,433 | 126.1 K to 128.4 K (+1.81 %) |
| Nov 07 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Gift | G | 0.00 | 2,288 | 0 | 2,715 | 5 K to 2.7 K (-45.73 %) |
| Nov 07 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Payment of Exercise | F | 73.46 | 2,212 | 162,494 | 5,003 | 7.2 K to 5 K (-30.66 %) |
| Nov 07 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Buy | M | 0.00 | 4,500 | 0 | 7,215 | 2.7 K to 7.2 K (+165.75 %) |
| Nov 03 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 21.58 | 73,333 | 1,582,159 | 73,333 | |
| Nov 03 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 75.60 | 7,477 | 565,295 | 2,996,766 | 3 M to 3 M (-0.25 %) |
| Nov 03 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 75.08 | 65,856 | 4,944,403 | 3,004,243 | 3.1 M to 3 M (-2.15 %) |
| Nov 03 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 21.58 | 73,333 | 1,582,159 | 3,070,099 | 3 M to 3.1 M (+2.45 %) |
| Nov 03 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Option Exercise | M | 24.91 | 8,625 | 214,806 | 24,751 | |
| Nov 03 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Sell | S | 75.48 | 1,600 | 120,773 | 62,363 | 64 K to 62.4 K (-2.50 %) |
| Nov 03 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Sell | S | 74.74 | 13,400 | 1,001,512 | 63,963 | 77.4 K to 64 K (-17.32 %) |
| Nov 03 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Buy | M | 24.91 | 8,625 | 214,806 | 77,363 | 68.7 K to 77.4 K (+12.55 %) |
| Oct 04 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Option Exercise | M | 24.91 | 17,250 | 429,611 | 33,376 | |
| Oct 04 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Sell | S | 83.52 | 2,141 | 178,819 | 68,738 | 70.9 K to 68.7 K (-3.02 %) |
| Oct 04 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Sell | S | 82.68 | 19,938 | 1,648,432 | 70,879 | 90.8 K to 70.9 K (-21.95 %) |
| Oct 04 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Sell | S | 81.84 | 2,921 | 239,056 | 90,817 | 93.7 K to 90.8 K (-3.12 %) |
| Oct 04 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Buy | M | 24.91 | 17,250 | 429,611 | 93,738 | 76.5 K to 93.7 K (+22.55 %) |
| Oct 04 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 21.58 | 73,333 | 1,582,159 | 146,666 | |
| Oct 04 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 82.62 | 68,133 | 5,628,855 | 2,996,766 | 3.1 M to 3 M (-2.22 %) |
| Oct 04 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 81.82 | 5,200 | 425,464 | 3,064,899 | 3.1 M to 3.1 M (-0.17 %) |
| Oct 04 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 21.58 | 73,333 | 1,582,159 | 3,070,099 | 3 M to 3.1 M (+2.45 %) |
| Oct 02 2017 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 134 | 0 | 21,048 | |
| Oct 02 2017 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | A | 0.00 | 173 | 0 | 27,154 | |
| Oct 02 2017 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 41 | 0 | 6,447 | |
| Sep 11 2017 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | M | 24.30 | 33,750 | 819,956 | 0 | |
| Sep 11 2017 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 85.00 | 18,070 | 1,535,950 | 103,477 | 121.5 K to 103.5 K (-14.87 %) |
| Sep 11 2017 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 85.00 | 33,750 | 2,868,750 | 9,602 | 43.4 K to 9.6 K (-77.85 %) |
| Sep 11 2017 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Buy | M | 24.30 | 33,750 | 819,956 | 43,352 | 9.6 K to 43.4 K (+351.49 %) |
| Sep 06 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Option Exercise | M | 24.91 | 17,250 | 429,611 | 50,626 | |
| Sep 06 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Sell | S | 83.54 | 3,737 | 312,207 | 76,488 | 80.2 K to 76.5 K (-4.66 %) |
| Sep 06 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Sell | S | 82.96 | 21,263 | 1,763,981 | 80,225 | 101.5 K to 80.2 K (-20.95 %) |
| Sep 06 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Buy | M | 24.91 | 17,250 | 429,611 | 101,488 | 84.2 K to 101.5 K (+20.48 %) |
| Sep 06 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 21.58 | 73,333 | 1,582,159 | 219,999 | |
| Sep 06 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 83.43 | 14,995 | 1,251,094 | 2,996,766 | 3 M to 3 M (-0.50 %) |
| Sep 06 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 83.03 | 58,338 | 4,843,897 | 3,011,761 | 3.1 M to 3 M (-1.90 %) |
| Sep 06 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 21.58 | 73,333 | 1,582,159 | 3,070,099 | 3 M to 3.1 M (+2.45 %) |
| Sep 06 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Gift | G | 0.00 | 129,870 | 0 | 2,996,766 | 3.1 M to 3 M (-4.15 %) |
| Sep 05 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Option Exercise | M | 21.00 | 60,000 | 1,260,000 | 0 | |
| Sep 05 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Sell | S | 83.64 | 16,700 | 1,396,775 | 2,715 | 19.4 K to 2.7 K (-86.02 %) |
| Sep 05 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Sell | S | 83.01 | 43,300 | 3,594,515 | 19,415 | 62.7 K to 19.4 K (-69.04 %) |
| Sep 05 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Buy | M | 21.00 | 60,000 | 1,260,000 | 62,715 | 2.7 K to 62.7 K (+2,209.94 %) |
| Sep 01 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Option Exercise | M | 26.99 | 21,001 | 566,817 | 0 | |
| Sep 01 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Option Exercise | M | 24.91 | 22,124 | 550,998 | 67,876 | |
| Sep 01 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Sell | S | 79.00 | 50,000 | 3,950,000 | 84,238 | 134.2 K to 84.2 K (-37.25 %) |
| Sep 01 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Buy | M | 26.99 | 21,001 | 566,817 | 134,238 | 113.2 K to 134.2 K (+18.55 %) |
| Sep 01 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Buy | M | 24.91 | 22,124 | 550,998 | 113,237 | 91.1 K to 113.2 K (+24.28 %) |
| Aug 31 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Gift | G | 0.00 | 115 | 0 | 126,145 | 126 K to 126.1 K (+0.09 %) |
| Aug 31 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Gift | G | 0.00 | 115 | 0 | 2,715 | 2.8 K to 2.7 K (-4.06 %) |
| Aug 31 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Grant | A | 59.76 | 115 | 6,873 | 2,830 | 2.7 K to 2.8 K (+4.24 %) |
| Aug 22 2017 | GILD | GILEAD SCIENCES IN ... | Kramer Kelly A. | Director | Option Exercise | M | 0.00 | 1,339 | 0 | 902 | |
| Aug 22 2017 | GILD | GILEAD SCIENCES IN ... | Kramer Kelly A. | Director | Buy | M | 0.00 | 1,339 | 0 | 1,339 | 0 to 1.3 K |
| Aug 14 2017 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Option Exercise | M | 0.00 | 910 | 0 | 4,712 | |
| Aug 14 2017 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Payment of Exercise | F | 72.70 | 453 | 32,933 | 6,688 | 7.1 K to 6.7 K (-6.34 %) |
| Aug 14 2017 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Buy | M | 0.00 | 910 | 0 | 7,141 | 6.2 K to 7.1 K (+14.60 %) |
| Aug 14 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Option Exercise | M | 0.00 | 820 | 0 | 8,960 | |
| Aug 14 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Gift | G | 0.00 | 525 | 0 | 126,030 | 125.5 K to 126 K (+0.42 %) |
| Aug 14 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Gift | G | 0.00 | 525 | 0 | 2,715 | 3.2 K to 2.7 K (-16.20 %) |
| Aug 14 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Payment of Exercise | F | 72.70 | 295 | 21,447 | 3,240 | 3.5 K to 3.2 K (-8.35 %) |
| Aug 14 2017 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Buy | M | 0.00 | 820 | 0 | 3,535 | 2.7 K to 3.5 K (+30.20 %) |
| Aug 03 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Option Exercise | M | 26.99 | 8,625 | 232,789 | 21,001 | |
| Aug 03 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Sell | S | 75.88 | 15,000 | 1,138,190 | 91,113 | 106.1 K to 91.1 K (-14.14 %) |
| Aug 03 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Buy | M | 26.99 | 8,625 | 232,789 | 106,113 | 97.5 K to 106.1 K (+8.85 %) |
| Aug 03 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 21.58 | 73,333 | 1,582,159 | 293,332 | |
| Aug 03 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 75.86 | 73,333 | 5,562,777 | 3,126,636 | 3.2 M to 3.1 M (-2.29 %) |
| Aug 03 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 21.58 | 73,333 | 1,582,159 | 3,199,969 | 3.1 M to 3.2 M (+2.35 %) |
| Jul 25 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Option Exercise | M | 26.99 | 34,500 | 931,155 | 29,626 | |
| Jul 25 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Sell | S | 74.00 | 5,500 | 407,000 | 97,488 | 103 K to 97.5 K (-5.34 %) |
| Jul 25 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Sell | S | 74.00 | 34,500 | 2,553,000 | 102,988 | 137.5 K to 103 K (-25.09 %) |
| Jul 25 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Buy | M | 26.99 | 34,500 | 931,155 | 137,488 | 103 K to 137.5 K (+33.50 %) |
| Jul 06 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 21.58 | 73,333 | 1,582,159 | 366,665 | |
| Jul 06 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 71.00 | 73,333 | 5,206,892 | 3,126,636 | 3.2 M to 3.1 M (-2.29 %) |
| Jul 06 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 21.58 | 73,333 | 1,582,159 | 3,199,969 | 3.1 M to 3.2 M (+2.35 %) |
| Jul 06 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Sell | S | 71.06 | 5,000 | 355,295 | 102,988 | 108 K to 103 K (-4.63 %) |
| Jul 05 2017 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | A | 0.00 | 953 | 0 | 26,980 | |
| Jul 03 2017 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 141 | 0 | 19,290 | |
| Jul 03 2017 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | A | 0.00 | 190 | 0 | 26,027 | |
| Jul 03 2017 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 47 | 0 | 6,405 | |
| Jun 05 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 21.58 | 73,333 | 1,582,159 | 293,332 | |
| Jun 05 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 65.24 | 73,333 | 4,784,531 | 3,199,969 | 3.3 M to 3.2 M (-2.24 %) |
| Jun 05 2017 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 21.58 | 73,333 | 1,582,159 | 3,273,302 | 3.2 M to 3.3 M (+2.29 %) |
| Jun 05 2017 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP Comm&Acs ALA, C ... | Sell | S | 65.02 | 5,000 | 325,114 | 107,988 | 113 K to 108 K (-4.43 %) |
| May 12 2017 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | A | 0.00 | 2,241 | 0 | 2,241 | |
| May 12 2017 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | A | 66.92 | 10,376 | 694,362 | 10,376 | |
| May 12 2017 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Option Exercise | A | 0.00 | 2,241 | 0 | 2,241 | |
| May 12 2017 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Option Exercise | A | 66.92 | 10,376 | 694,362 | 10,376 | |
| May 12 2017 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | A | 0.00 | 2,241 | 0 | 23,377 | |
| May 12 2017 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | A | 66.92 | 10,376 | 694,362 | 10,376 | |
| May 12 2017 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 2,241 | 0 | 4,028 |